NATURAL ALTERNATIVES INTERNATIONAL INC Capital Expenditures Incurred but Not yet Paid
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) reported Capital Expenditures Incurred but Not yet Paid of $387.00 thousand for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-19.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-05-19
- NATURAL ALTERNATIVES INTERNATIONAL INC capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was -$352.00K.
- NATURAL ALTERNATIVES INTERNATIONAL INC capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $704.00K.
- NATURAL ALTERNATIVES INTERNATIONAL INC capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $35.00K.
- NATURAL ALTERNATIVES INTERNATIONAL INC capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $0.00.
- NATURAL ALTERNATIVES INTERNATIONAL INC capital expenditures incurred but not yet paid for fiscal 2015 was $14.00K, a 65.85% decline from fiscal 2014.
- NATURAL ALTERNATIVES INTERNATIONAL INC capital expenditures incurred but not yet paid for fiscal 2014 was $41.00K, a 64.00% increase from fiscal 2013.
- NATURAL ALTERNATIVES INTERNATIONAL INC capital expenditures incurred but not yet paid for fiscal 2013 was $25.00K, a 0.00% change from fiscal 2012.
- NATURAL ALTERNATIVES INTERNATIONAL INC capital expenditures incurred but not yet paid for fiscal 2012 was $25.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$352.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-19 | $352.00K derived: sum of 2 quarters · filed 2026-05-19 | $387.00K 10-Q · filed 2026-05-19 | |
| 2025-12-31 | $704.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | $739.00K 10-Q · filed 2026-02-13 | ||
| 2025-09-30 | $35.00K 10-Q · filed 2025-11-12 | |||
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-19 | $0.00 derived: sum of 2 quarters · filed 2026-05-19 | $0.00 10-Q · filed 2026-05-19 | |
| 2024-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | $0.00 10-Q · filed 2026-02-13 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-12 | |||
| 2015-06-30 | $14.00K 10-K · filed 2015-09-18 | |||
| 2014-09-30 | $11.00K 10-Q · filed 2014-11-12 | $47.00K derived: sum of 2 quarters · filed 2015-09-18 | $23.00K derived: sum of 3 quarters · filed 2015-09-18 | -$9.00K derived: sum of 4 quarters · filed 2015-09-18 |
| 2014-06-30 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-18 | $12.00K derived: sum of 2 quarters · filed 2015-09-18 | -$20.00K derived: sum of 3 quarters · filed 2015-09-18 | $41.00K 10-K · filed 2015-09-18 |
| 2014-03-31 | -$24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-12 | -$56.00K derived: sum of 2 quarters · filed 2015-05-12 | $5.00K 10-Q · filed 2015-05-12 | |
| 2013-12-31 | -$32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-12 | $29.00K 10-Q · filed 2015-02-12 | ||
| 2013-09-30 | $61.00K 10-Q · filed 2014-11-12 | |||
| 2013-06-30 | $25.00K 10-K · filed 2014-09-25 | |||
| 2012-12-31 | $5.00K 10-Q · filed 2014-02-12 | |||
| 2012-06-30 | $25.00K 10-K · filed 2013-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |